Chief Scientific Officer

Trials

Studies that name Chief Scientific Officer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:16 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07228975 · Pilot Study on a Dietary Supplement With EndoGen™ as Adjunct Therapy in Women With Endometriosis

  Endok s.r.l. · completed · Endometriosis · study director
• Ph1/Ph2
  NCT07096934 · Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

  FibroBiologics · recruiting · Diabetic Foot Ulcer (DFU) · principal investigator
• N/A
  NCT06949631 · Study on the Effects of Resistant Potato Starch on Gut Bacteria in Healthy Adults

  MSP Starch Products Inc. · completed · Gastrointestinal Microbiota · study director
• Ph2
  NCT06776432 · Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

  Shionogi · active not recruiting · Sleep Apnea · study director
• N/A
  NCT06566716 · A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women With an Ovarian Mass

  Cleo Diagnostics Ltd · active not recruiting · Ovarian Neoplasms · study director
• Ph2
  NCT06095505 · A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

  Puma Biotechnology, Inc. · recruiting · Small Cell Lung Cancer · study director
• Ph1/Ph2
  NCT05322590 · BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

  Bexion Pharmaceuticals, Inc. · active not recruiting · Metastatic Colorectal Carcinoma, Neuropathy · study director
• Ph1
  NCT04690426 · PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers

  Provention Bio, Inc. · completed · Viral; Infection, Coxsackie(Virus) · principal investigator
• Ph2
  NCT04366713 · A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib

  Puma Biotechnology, Inc. · completed · HER2 Amplified Breast Cancer · study director
• Ph2
  NCT02400476 · An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

  Puma Biotechnology, Inc. · completed · Early Stage HER2+ Breast Cancer · study director
• Ph2
  NCT01953926 · Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

  Puma Biotechnology, Inc. · terminated · Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations · study director
• Ph2
  NCT01026051 · Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

  Mannkind Corporation · terminated · Stage III Melanoma, Stage IV Melanoma · study chair
• Ph3
  NCT00332488 · Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes

  Mannkind Corporation · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT00056628 · COGNIShunt® System for Alzheimer's Disease

  Eunoe · completed · Alzheimer Disease · study director
• Ph1/Ph2
  NCT00033228 · Vaccine Therapy in Treating Patients With Stage IV Melanoma

  Mannkind Corporation · completed · Melanoma (Skin) · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.